1. Progressive tau aggregation does not alter functional brain network connectivity in seeded hTau.P301L mice

   Detrez, J. R., Ben-Nejma, I. R. H., Van Kolen, K., Van Dam, D., De Deyn, P. P., Fransen, E., Verhoye, M., Timmermans, J-P., Nuydens, R., Van der Linden, A., Keliris, G. A. & De Vos, W. H., Sep-2020, In : Neurobiology of Disease. 143, 13 p., 105011.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Pentylenetetrazole-induced Seizure Susceptibility in the Tau58/4 Transgenic Mouse Model of Tauopathy

   Van Erum, J., Valkenburg, F., Van Dam, D. & De Deyn, P. P., 15-Jan-2020, In : Neuroscience. 425, p. 112-122 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Sleep architecture changes in the APP23 mouse model manifest at onset of cognitive deficits

   Van Erum, J., Van Dam, D., Sheorajpanday, R. & De Deyn, P. P., 5-Nov-2019, In : Behavioural Brain Research. 373, 9 p., 112089.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Alzheimer's disease: Neurotransmitters of the sleep-wake cycle

   Van Erum, J., Van Dam, D. & De Deyn, P. P., Oct-2019, In : Neuroscience and Biobehavioral Reviews. 105, p. 72-80 9 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

5. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?

   Van Dam, D. & De Deyn, P. P., 8-Oct-2019, In : Expert Opinion on Drug Discovery. 3 p.

   Research output: Contribution to journal › Editorial › Academic › peer-review

View all (57) »